Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Glucose monitoring in women with polycystic ovary syndrome

Official title: Glucose Profiles in Women With Polycystic Ovary Syndrome

Run by Centre Hospitalier Universitaire, Amiens · NCT07483723 · Data updated 2026-11-12

This project will use continuous glucose monitors to see if daily glucose patterns differ among adult women with different PCOS phenotypes.

More Insulin Resistance trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment80 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Salouël)
StatusRecruiting
StartedJanuary 6, 2026
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedMarch 19, 2026
Trial IDNCT07483723 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women (>18 years) with a clinical diagnosis of PCOS who are not pregnant, agree to wear the FreeStyle Libre Pro sensor, and meet the trial's medication and exclusion criteria are ideal candidates.

Probably not a fit

Women with pre-existing diabetes, current pregnancy or breastfeeding, or recent use of excluded hormonal or metabolic treatments are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project uses continuous glucose monitoring to characterize daily glucose patterns in adult women diagnosed with PCOS and to compare these patterns across the four recognized PCOS phenotypes (A–D). Participants will be classified by reproductive and biochemical features (menstrual irregularity, hyperandrogenism, ovarian morphology or AMH levels) and will wear a FreeStyle Libre Pro sensor to collect interstitial glucose readings over the monitoring period. Investigators will analyze glucose parameters such as mean glucose, time-in-range, glycemic variability, and episodes of hyperglycemia, and will compare these metrics between phenotypes while accounting for factors like insulin resistance and BMI. The aim is to determine whether certain PCOS phenotypes have worse glucose profiles that warrant closer metabolic surveillance.

Why it matters

Potential benefit: If successful, the results could identify PCOS phenotypes at higher risk of glucose abnormalities and help target earlier screening or preventive care.

How similar studies have gone: Continuous glucose monitoring has been applied in metabolic research, but few prior studies have directly compared CGM-derived glucose profiles across PCOS phenotypes, so this phenotype-focused approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years at inclusion criteria
* Patient with polycystic ovary syndrome, defined by the presence of at least 2/3 irregular menstrual cycles, clinical or biological hyperandrogenism, polycystic ovary morphology (pelvic ultrasound) or elevated AMH levels, after the exclusion of other disorders.
* Agreed to carry the FSL pro
* Signed informed consent

Exclusion Criteria:

* Pregnancy, breast-feeding
* Differential diagnoses: hyperprolactinemia, dysthyroidism, Cushing's syndrome, congenital adrenal hyperplasia, virilizing tumor (ovarian or adrenal), intake of exogenous androgens
* Pre-existing diabetes
* Patient treated within 3 months prior to inclusion/data collection with estrogen-progestin contraception, progestin contraception, antidiabetic drugs, inositol, antiandrogen

Where it's running

  • CHRU Amiens
    Salouël, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.